» Articles » PMID: 30356247

Regional Reports for the Subnational Monitoring of Measles Elimination in Italy and the Identification of Local Barriers to the Attainment of the Elimination Goal

Overview
Journal PLoS One
Date 2018 Oct 26
PMID 30356247
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Although most countries in the WHO European Region were verified in 2017 as having interrupted endemic measles transmission, nine countries were still endemic. Among these, Italy accounted for the second highest number of measles cases reported in Europe in 2017. The elimination of measles is verified at national level by each country's National Verification Committee (NVC) through the production of an Annual Status Update (ASU). Since in Italy decentralization has led to an inhomogeneous implementation of immunization strategies among the 21 administrative Regions, the Italian NVC proposed that measles elimination should also be documented at the subnational level through regional ASUs and Synthetic Regional Reports (SRRs). The regional ASUs and the SRRs for 2014, 2015 and 2016 were produced and appraised by the NVC to evaluate the Regions' performances in each individual year as well as over the whole period. A specific analysis of vaccination coverage, including official immunization data for 2017, was performed. Moreover, the measles epidemic of 2017 was examined. Firstly, in the period 2014-2016, low immunization rates were registered in most Regions. Sixty-three per cent of southern Regions reported rates below the national mean and an overall low-quality performance. The approval of Italy's mandatory vaccination law in 2017 resulted in a marked increase in vaccination coverage; however, this increase was not homogeneous among Regions. Secondly, more than 50% of Regions did not report any supplemental immunization activity (SIA) for the period 2014-2016. Thirdly, from 2014 to 2016, fewer than one-third of Regions improved their reporting of outbreaks. Finally, over the study period, only two Regions reached the target required by the WHO for measles laboratory investigations. In countries with decentralized health policies, subnational monitoring can help identify local barriers to measles elimination. In Italy it has highlighted the need for further SIAs and a stronger surveillance system.

Citing Articles

Measles epidemiological surveillance system before and during the COVID-19 pandemic in Pernambuco, Brazil, 2018-2022: a descriptive evaluation.

Souza C, Vanderlei L, Frias P Epidemiol Serv Saude. 2023; 32(3):e2023545.

PMID: 38018649 PMC: 10684126. DOI: 10.1590/S2237-96222023000300008.EN.


Measles vaccine uptake among Italian medical students compared to the pre-COVID-19 era.

Ferrari C, Somma G, Olesen O, Buonomo E, Pasanisi Zingarello M, Mazza A Hum Vaccin Immunother. 2023; 19(2):2252681.

PMID: 37649435 PMC: 10472847. DOI: 10.1080/21645515.2023.2252681.


Evolving measles status and immunization policy development in six European countries.

Vojtek I, Larson H, Plotkin S, Van Damme P Hum Vaccin Immunother. 2022; 18(1):2031776.

PMID: 35180372 PMC: 9009904. DOI: 10.1080/21645515.2022.2031776.


Effect of the mandatory vaccination law on measles and rubella incidence and vaccination coverage in Italy (2013-2019).

Sindoni A, Baccolini V, Adamo G, Massimi A, Migliara G, De Vito C Hum Vaccin Immunother. 2021; 18(1):1950505.

PMID: 34346840 PMC: 8920156. DOI: 10.1080/21645515.2021.1950505.


MAGNITUDE AND ASSOCIATED FACTORS OF DELAYED VACCINATION AMONG CHILDREN AGED11 -23 MONTHS IN, TIGRAY, ETHIOPIA, 2018.

Gebru Gebremeskel T, Hagos M, Kassahun S, Gebrezgiher B Hum Vaccin Immunother. 2021; 17(10):3831-3837.

PMID: 34292123 PMC: 8437483. DOI: 10.1080/21645515.2021.1934356.


References
1.
Rosso A, Marzuillo C, Massimi A, De Vito C, de Belvis A, La Torre G . Policy and planning of prevention in Italy: Results from an appraisal of prevention plans developed by Regions for the period 2010-2012. Health Policy. 2015; 119(6):760-9. DOI: 10.1016/j.healthpol.2015.03.012. View

2.
De Vito C, Massimi A, Di Thiene D, Rosso A, DAndrea E, Vacchio M . Low level of attention to health inequalities in prevention planning activities of the Italian Regions. Int J Equity Health. 2016; 15:28. PMC: 4759742. DOI: 10.1186/s12939-016-0318-8. View

3.
Rosso A, De Vito C, Marzuillo C, Massimi A, DAndrea E, Villari P . The negative effect of financial constraints on planning prevention activities: some evidence from the Italian experience. Eur J Public Health. 2015; 25(6):1117-9. PMC: 4668326. DOI: 10.1093/eurpub/ckv087. View

4.
DAlessandro A, Napolitano F, DAmbrosio A, Angelillo I . Vaccination knowledge and acceptability among pregnant women in Italy. Hum Vaccin Immunother. 2018; 14(7):1573-1579. PMC: 6067873. DOI: 10.1080/21645515.2018.1483809. View

5.
Muscat M, Ben Mamou M, Reynen-de Kat C, Jankovic D, Hagan J, Singh S . Progress and Challenges in Measles and Rubella Elimination in the WHO European Region. Vaccines (Basel). 2024; 12(6). PMC: 11209032. DOI: 10.3390/vaccines12060696. View